Effectiveness of Harpagophytum extracts and clinical efficacy

被引：35

作者：

Chrubasik, S ^{[1
]}

Conradt, C

Roufogalis, BD

机构：

[1] Univ Sydney, Fac Pharm, Herbal Med Res & Educ Ctr, Sydney, NSW 2006, Australia

[2] Univ Freiburg, Dept Forens Med, D-79104 Freiburg, Germany

[3] Heidelberg Univ, Dept Med Biometry, D-69120 Heidelberg, Germany

来源：

PHYTOTHERAPY RESEARCH | 2004年 / 18卷 / 02期

关键词：

Harpagophytum; analgesia; osteoarthritis; low back pain;

D O I：

10.1002/ptr.1416

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Various preparations from Harpagophytum procumbens are used for the treatment of pain in the joints and lower back. Studies published in peer reviewed journals were examined for their clinical evidence. The studies offering preparations with 50-60 mg harpagoside in the daily dosage are of better quality and provide more reliable evidence on efficacy than a proprietary ethanol extract with half the amount of harpagoside per day. However, confirmatory studies are required for all extracts before they can gain a place in treatment guidelines. Copyright (C) 2004 John Wiley Sons, Ltd.

引用

页码：187 / 189

页数：3

共 15 条

[1]

Blumenthal M., 1998, COMPLETE GERMAN COMM

[2] Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis [J].

Chantre, P ;

Cappelaere, A ;

Leblan, D ;

Guedon, D ;

Vandermander, J ;

Fournie, B .

PHYTOMEDICINE, 2000, 7 (03) :177-183

[3]

Chrubasik S, 1999, EUR J ANAESTH, V16, P118

[4] A randomized double-blind pilot study comparing Doloteffin® and Vioxx® in the treatment of low back pain [J].

Chrubasik, S ;

Model, A ;

Black, A ;

Pollak, S .

RHEUMATOLOGY, 2003, 42 (01) :141-148

[5]

Chrubasik S, 1996, PHYTOMEDICINE, V3, P1, DOI 10.1016/S0944-7113(96)80003-1

[6] Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin® in patients with pain in the lower back, knee or hip [J].

Chrubasik, S ;

Thanner, J ;

Künzel, O ;

Conradt, C ;

Black, A ;

Pollak, S .

PHYTOMEDICINE, 2002, 9 (03) :181-194

[7]

CHRUBASIK S, 2001, AUST J PHARM, V82, P444

[8]

CHRUBASIK S, 1996, FORSCH KOMPLEMENTMED, V3, P116

[9]

Chrubasik S., 1996, COMPLEMENT MED RES, V3, P57, DOI [10.1159/000210204, DOI 10.1159/000210204]

[10]

*ESCOP, 1996, ESCOP MON

← 1 2 →